Group VR experiences can produce ego attenuation and connectedness comparable to psychedelics
Using a distributed multi‑person VR framework called Isness‑D, the authors show that group VR experiences can induce self‑transcendent states—marked reductions in ego‑sense and increased connectedness—that are statistically indistinguishable from recent psychedelic studies on four established self‑report scales (N = 58). This demonstrates that distributed VR can reliably evoke embodied intersubjective "energetic coalescence" and may offer a non‑pharmacological route to psychedelic‑like therapeutic phenomenology.
Authors
- Glowacki, D. R.
- Wonnacott, M. D.
- Freire, R.
Published
Abstract
With a growing body of research highlighting the therapeutic potential of experiential phenomenology which diminishes egoic identity and increases one’s sense of connectedness, there is significant interest in how to elicit such ‘self-transcendent experiences’ (STEs) in laboratory contexts. Psychedelic drugs (YDs) have proven particularly effective in this respect, producing subjective phenomenology which reliably elicits intense STEs. With virtual reality (VR) emerging as a powerful tool for constructing new perceptual environments, we describe a VR framework called ‘Isness-distributed’ (Isness-D) which harnesses the unique affordances of distributed multi-person VR to blur conventional self-other boundaries. Within Isness-D, groups of participants co-habit a shared virtual space, collectively experiencing their bodies as luminous energetic essences with diffuse spatial boundaries. It enables moments of ‘energetic coalescence’, a new class of embodied intersubjective experience where bodies can fluidly merge, enabling participants to include multiple others within their self-representation. To evaluate Isness-D, we adopted a citizen science approach, coordinating an international network of Isness-D 'nodes'. We analyzed the results (N = 58) using 4 different self-report scales previously applied to analyze subjective YD phenomenology (the inclusion of community in self scale, ego-dissolution inventory, communitas scale, and the MEQ30 mystical experience questionnaire). Despite the complexities associated with a distributed experiment like this, the Isness-D scores on all 4 scales were statistically indistinguishable from recently published YD studies, demonstrating that distributed VR can be used to design intersubjective STEs where people dissolve their sense of self in the connection to others.
Research Summary of 'Group VR experiences can produce ego attenuation and connectedness comparable to psychedelics'
Introduction
Self-transcendent experiences (STEs) are transient mental states in which the subjective sense of the self as an isolated entity diminishes and a feeling of unity with others or the environment emerges. Earlier research across psychology, neuroscience and religious studies has identified a spectrum of STEs—ranging from mild ‘‘flow’’ states to intense mystical-type experiences (MTEs)—and has highlighted two core phenomenological ingredients: (1) attenuation or ‘‘annihilation’’ of self-boundaries and self-salience, and (2) a relational sense of unity with something beyond the self. Psychedelic drugs (YDs) reliably elicit intense STEs and MTEs and have been associated with enduring positive changes in wellbeing, but they pose practical, regulatory, and safety challenges for wider use in laboratory and clinical settings. Glowacki and colleagues propose virtual reality (VR) as an alternative technology capable of designing STEs without pharmacology. Their prior co-located multi-person VR system (Isness-C) represented participants as luminous energetic bodies and produced MEQ30 scores statistically similar to moderate-to-high doses of YDs. Building on that work, the present paper introduces Isness-distributed (Isness-D), a cloud-hosted multi-person VR experience that connects geographically dispersed participants. The authors aim to evaluate whether Isness-D can elicit intersubjective STEs—especially a novel group phenomenon they call ‘‘energetic coalescence,’’ where participants’ diffuse virtual bodies fluidly overlap—and to compare subjective outcomes to those reported in psychedelic research using established psychometric scales.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typeindividual
- Journal
- APA Citation
Glowacki, D. R., Williams, R. R., Wonnacott, M. D., Maynard, O. M., Freire, R., Pike, J. E., & Chatziapostolou, M. (2022). Group VR experiences can produce ego attenuation and connectedness comparable to psychedelics. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-12637-z
References (30)
Papers cited by this study that are also in Blossom
Griffiths, R. R. · Journal of Psychopharmacology (2008)
Griffiths, R. R., Hurwitz, E. S., Davis, A. K. et al. · PLOS ONE (2019)
Griffiths, R. R., Richards, W. A., Mccann, U. et al. · Journal of Psychopharmacology (2006)
Griffiths, R. R., Johnson, M. W., Richards, W. A. et al. · Psychopharmacology (2011)
Carhart-Harris, R. L., Friston, K. J. · Pharmacological Reviews (2019)
Carhart-Harris, R. L., Giribaldi, B., Watts, R. et al. · New England Journal of Medicine (2021)
Millière, R. · Frontiers in Human Neuroscience (2017)
Timmermann, C., Roseman, L., Williams, L. et al. · Frontiers in Psychology (2018)
Wittmann, M., Hasler, F., Vollenweider, F. X. · Neuroscience Letters (2008)
Johnson, M. W., Hendricks, P. S., Barrett, F. S. et al. · Pharmacology and Therapeutics (2019)
Show all 30 referencesShow fewer
Aday, J. S., Davoli, C. C., Bloesch, E. K. · Therapeutic Advances in Psychopharmacology (2020)
Glowacki, D. R., Wonnacott, M. D., Freire, R. et al. · Association for Computing Machinery (2020)
MacLean, K. A., Leoutsakos, J. S., Johnson, M. W. et al. · Journal for the Scientific Study of Religion (2012)
Barrett, F. S., Johnson, M. W., Griffiths, R. R. · Journal of Psychopharmacology (2015)
Hendricks, P. S. · International Review of Psychiatry (2018)
Tagliazucchi, E., Roseman, L., Kaelen, M. et al. · Current Biology (2016)
Holze, F., Vizeli, P., Müller, F. et al. · Neuropsychopharmacology (2019)
Madsen, M. K., Fisher, P. M., Burmester, D. et al. · Neuropsychopharmacology (2019)
Kettner, H., Rosas, F. E., Timmermann, C. et al. · Frontiers in Pharmacology (2021)
Watts, R., Day, C. M., Krzanowski, J. et al. · Journal of Humanistic Psychology (2017)
Barsuglia, J. P., Davis, A. K., Palmer, R. et al. · Frontiers in Psychology (2018)
Griffiths, R. R., Johnson, M. W., Richards, W. A. et al. · Journal of Psychopharmacology (2017)
Nicholas, C. R., Henriquez, K. M., Gassman, M. C. et al. · Journal of Psychopharmacology (2018)
Carbonaro, T. M., Hurwitz, E., Johnson, M. W. · Psychopharmacology (2017)
Liechti, M. E., Dolder, P. C., Schmid, Y. · Psychopharmacology (2016)
Barrett, F. S., Griffiths, R. R. · Current Topics in Behavioral Neurosciences (2017)
Forstmann, M., Yudkin, D. A., Prosser, A. M. B. et al. · PNAS (2020)
Nour, M. R., Evans, J., Nutt, D. J. et al. · Frontiers in Human Neuroscience (2016)
Studerus, E., Gamma, A., Kometer, M. et al. · PLOS ONE (2012)
Carhart-Harris, R. L., Erritzoe, D., Haijen, E. C. H. M. et al. · Psychopharmacology (2017)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.